Thioguanine

硫鸟嘌呤

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameThioguanine
Drug Alias Nametioguanina巯基鸟嘌呤tioguanine6-Thioguaninetioguaninum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaLeukemia, Myelogenous, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Original Approved Country/TerritoryUnited States
Original Approved Date1966/01/18
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAspen Pharma
China Registration ClassN/A

Develop Information

Active CompaniesWaylis Therapeutics LLCDonghai Pharmaceutical Factory of Shanghai Donghai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01BB03
Related LinksWikipediaDrugBankKEGG